Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast
- PMID: 12440819
Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast
Abstract
Medullary carcinoma (MC) of the breast is considered to carry a more favorable prognosis than other subtypes of infiltrating ductal carcinoma. This is a biological paradox because its clinical behavior contrasts with its anaplastic morphology. MC is characterized by a dense lymphocytic infiltrate. In this study, we determined the immunological profile of tumor infiltrating lymphocytes (TILs) in MC by CD20 (L26), CD8, and CD45RO (UCHL 1) immunostaining on paraffin-embedded sections. We examined 14 cases of typical MC (TMC), 15 cases of atypical MC (AMC) classified according to Ridolfi criteria (1977) and 19 cases of poorly differentiated infiltrating ductal carcinoma (PDC-NOS). TILs were quantified separately into cells infiltrating tumor nests (intraepithelial) and cells infiltrating tumor stroma (stromal). The number of CD8 positive and CD20 positive cells infiltrating tumor nests and tumor stroma were significantly increased in TMC and AMC as opposed to the PDC-NOS group. There was a loss in the number of CD45RO positive cells, both intraepithelial and stromal, in TMC and AMC as opposed to the PDC-NOS group. We conclude that MC tumor lymphocytic infiltrate demonstrates a mixed-T cytotoxic (CD8+) and B cell (CD20+)-immunophenotypic profile. This might in part explain the improved clinical outcome of the disease.
Similar articles
-
Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.Cancer Immun. 2010 Jan 22;10:3. Cancer Immun. 2010. PMID: 20092246 Free PMC article.
-
Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.Mod Pathol. 1999 Nov;12(11):1050-6. Mod Pathol. 1999. PMID: 10574602
-
Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.J Pathol. 2000 Oct;192(2):166-73. doi: 10.1002/1096-9896(2000)9999:9999<::AID-PATH689>3.0.CO;2-A. J Pathol. 2000. PMID: 11004692
-
Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.Hum Pathol. 2017 Dec;70:129-138. doi: 10.1016/j.humpath.2017.10.020. Epub 2017 Nov 6. Hum Pathol. 2017. PMID: 29122657
-
Poorly differentiated medullary carcinoma of the colon with an unusual phenotypic profile mimicking high grade large cell lymphoma - a unique case report and review of the literature.Int J Clin Exp Pathol. 2014 Jan 15;7(2):828-34. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24551312 Free PMC article. Review.
Cited by
-
Rapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity.BMC Cancer. 2008 Jun 21;8:176. doi: 10.1186/1471-2407-8-176. BMC Cancer. 2008. PMID: 18570671 Free PMC article.
-
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas.Pathobiology. 2020;87(2):125-142. doi: 10.1159/000507055. Epub 2020 Apr 23. Pathobiology. 2020. PMID: 32325459 Free PMC article. Review.
-
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.PLoS One. 2009 Jul 29;4(7):e6412. doi: 10.1371/journal.pone.0006412. PLoS One. 2009. PMID: 19641607 Free PMC article.
-
Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.Cancer Immun. 2010 Jan 22;10:3. Cancer Immun. 2010. PMID: 20092246 Free PMC article.
-
Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.Virchows Arch. 2005 Jan;446(1):10-4. doi: 10.1007/s00428-004-1143-9. Epub 2004 Nov 30. Virchows Arch. 2005. PMID: 15660281
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials